Gelomics Achieves Triple ISO Certification, Reinforcing Global Leadership in Biomedical Innovation

We’re proud to share an exciting milestone for the Gelomics team: we’ve officially been awarded ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications! These internationally recognized standards reflect our commitment to quality, environmental responsibility, and the health and safety of our team. The certifications were awarded on June 4, 2025, and mark a new […]
Gelomics Partners with Morpho Biotech for Benelux Distribution

At Gelomics, we are committed to making cutting-edge, animal-free research tools more accessible to scientists around the globe. Today, we’re excited to announce a new strategic partnership with Morpho Biotech, who will serve as the exclusive distributor of Gelomics products in the Netherlands, Belgium, and Luxembourg (Benelux) starting July 1st, 2025. Morpho Biotech is a […]
Gelomics Partners with BioNordika Group to Expand Presence Across the Nordics and Baltics

We’re excited to announce that Gelomics is now a registered supplier on BioNordika! Our cutting-edge 3D cell culture technologies are now accessible to researchers across the Nordic and Baltic regions. BioNordika is a trusted distributor representing a wide range of world-leading and innovative life science suppliers. Their portfolio includes comprehensive workflow solutions in immunology, diagnostics, […]
Gelomics Welcomes Distinguished Professor Gail Risbridger to its Scientific Advisory Board

Gelomics, a pioneering Australian biotech firm redefining the future of drug development with its cutting-edge 3D tissue culture technologies, is delighted to announce the appointment of Distinguished Professor Gail Risbridger AM to its Scientific Advisory Board. Professor Risbridger joins a team of internationally recognized scientific leaders, bringing a wealth of expertise in translational research […]
Gelomics Partners with SLS to Expand 3D Tissue Culture Access Across the UK and Ireland

Gelomics is proud to announce a strategic distribution partnership with Scientific Laboratory Supplies (SLS), the United Kingdom’s largest independent supplier of laboratory products. Under this agreement, SLS will serve as Gelomics’ exclusive distributor in the UK and Ireland, significantly expanding access to our advanced 3D tissue culture systems for researchers across the region. Empowering Researchers […]
Gelomics Now Available on Scientist.com

We are excited to announce that Gelomics is now a supplier on Scientist.com! Through this leading platform for scientific sourcing, we are providing simple, fast and reliable access to our innovative 3D tissue culture products and services in the US. Why choose Gelomics on Scientist.com? Since 2007, Scientist.com has become a trusted supplier for the […]
Gelomics Expands Global Presence with New Distribution Partner, Voden Medical In Italy

Gelomics proudly announces a strategic partnership with Voden Medical. Voden Medical is a renowned provider of advanced diagnostic and life science solutions in Italy. Under this agreement, Voden Medical will serve as Gelomics’ exclusive distributor in the Italian market. This partnership, effective January 2025, marks a significant step forward in Gelomics’ mission to bring our […]
Gelomics partners with Bucher Biotec AG for Product Distribution in Switzerland

Gelomics is pleased to announce a new strategic partnership with Bucher Biotec AG, a leading provider of advanced life science solutions in Switzerland & Lichtenstein. Under this agreement, Bucher Biotec will serve as Gelomics’ exclusive distributor across the Swiss market. This partnership marks an important milestone for Gelomics as we expand our presence in Europe. […]
Gelomics announces appointment of Distinguished Professor Dietmar W. Hutmacher, PhD, MBA and Professor Travis J. Klein, PhD to its Scientific Advisory Board

Gelomics, a leading Australian biotech firm at the forefront of drug development innovation, is further strengthening its Scientific Advisory Board with the addition of Distinguished Professor Dietmar W. Hutmacher, PhD, MBA, and Professor Travis J. Klein, PhD. Following the recent appointment of Professor Dame Molly Stevens, FREng FRS, these new appointments reinforce our commitment to […]
LunaGel™ Ultrapure GelMA ECM Is Now Available

We’re thrilled to unveil our latest innovation! LunaGel™ Ultrapure GelMA Photocrosslinkable Extracellular Matrix (ECM), now available in both High Stiffness and Low Stiffness options. Developed in collaboration with Rousselot Biomedical, this breakthrough leverages the advanced X-Pure® GelMA technology, setting a new standard for 3D cell culture by offering unparalleled control over matrix porosity and stiffness. […]